scholarly journals Underlying Histopathology Determines Response to Oxidative Stress in Cultured Human Primary Proximal Tubular Epithelial Cells

2020 ◽  
Vol 21 (2) ◽  
pp. 560
Author(s):  
Muhammad Ali Khan ◽  
Xiangju Wang ◽  
Kurt T.K. Giuliani ◽  
Purba Nag ◽  
Anca Grivei ◽  
...  

Proximal tubular epithelial cells (PTEC) are key players in the progression of kidney diseases. PTEC studies to date have primarily used mouse models and transformed human PTEC lines. However, the translatability of these models to human kidney disease has been questioned. In this study, we investigated the phenotypic and functional response of human primary PTEC to oxidative stress, an established driver of kidney disease. Furthermore, we examined the functional contribution of the underlying histopathology of the cortical tissue used to generate our PTEC. We demonstrated that human primary PTEC from both histologically ‘normal’ and ‘diseased’ cortical tissue responded to H2O2-induced oxidative stress with significantly elevated mitochondrial superoxide levels, DNA damage, and significantly decreased proliferation. The functional response of ‘normal’ PTEC to oxidative stress mirrored the reported pathogenesis of human kidney disease, with significantly attenuated mitochondrial function and increased cell death. In contrast, ‘diseased’ PTEC were functionally resistant to oxidative stress, with maintenance of mitochondrial function and cell viability. This selective survival of ‘diseased’ PTEC under oxidizing conditions is reminiscent of the in vivo persistence of maladaptive PTEC following kidney injury. We are now exploring the impact that these differential PTEC responses have in the therapeutic targeting of oxidative stress pathways.

2002 ◽  
pp. 253-259 ◽  
Author(s):  
AKSHAY BHANDARI ◽  
SWEATY KOUL ◽  
AVTAR SEKHON ◽  
SAROJ K. PRAMANIK ◽  
LAKSHMI S. CHATURVEDI ◽  
...  

1999 ◽  
Vol 7 (4) ◽  
pp. 306-313 ◽  
Author(s):  
Patrick C. Baer ◽  
Ulf W. Tunn ◽  
German Nunez ◽  
Jürgen E. Scherberich ◽  
Helmut Geiger

2003 ◽  
Vol 17 (8) ◽  
pp. 1-21 ◽  
Author(s):  
David A. Allen ◽  
Steven M. Harwood ◽  
Mira Varagunam ◽  
Martin J. Raftery ◽  
Muhammad M. Yaqoob

1989 ◽  
Vol 48 (2) ◽  
pp. 296-301 ◽  
Author(s):  
A. M. M. MILTENBURG ◽  
M. E. MEIJER-PAAPE ◽  
M. R. DAHA ◽  
J. H. VAN BOCKEL ◽  
J. J. WEENING ◽  
...  

2020 ◽  
Author(s):  
Ryan M. Williams ◽  
Janki Shah ◽  
Elizabeth Mercer ◽  
Helen S. Tian ◽  
Justin M. Cheung ◽  
...  

AbstractCisplatin-induced acute kidney injury (CI-AKI) is a significant co-morbidity of chemotherapeutic regimens. While this condition is associated with substantially lower survival and increased economic burden, there is no pharmacological agent to effectively treat CI-AKI. The disease is hallmarked by acute tubular necrosis of the proximal tubular epithelial cells primarily due to increased oxidative stress. In our prior work, we developed a highly-selective kidney-targeted mesoscale nanoparticle (MNP) that accumulates primarily in the renal proximal tubular epithelial cells while exhibiting no toxicity. Here, we found that MNPs exhibit renal-selective targeting in multiple mouse models of tumor growth with virtually no tumor accumulation. We then evaluated the therapeutic efficacy of MNPs loaded with the reactive oxygen species scavenger edaravone in a mouse model of CI-AKI. We found a marked and significant therapeutic effect with this approach as compared to free drug or empty control MNPs, including improved renal function, histology, and diminution of oxidative stress. These results indicated that renal-selective MNP edaravone delivery holds substantial potential in the treatment of acute kidney injury among patients undergoing cisplatin-based chemotherapy.


Sign in / Sign up

Export Citation Format

Share Document